These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12461012)

  • 1. Activity of ketolide ABT-773 (cethromycin) against erythromycin-resistant Streptococcus pneumoniae: correlation with extended MLSK phenotypes.
    Hamilton-Miller JM; Shah S
    J Antimicrob Chemother; 2002 Dec; 50(6):907-13. PubMed ID: 12461012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides.
    Mason EO; Lamberth LB; Wald ER; Bradley JS; Barson WJ; Kaplan SL
    Antimicrob Agents Chemother; 2003 Jan; 47(1):166-9. PubMed ID: 12499186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipneumococcal activity of ABT-773 compared to those of 10 other agents.
    Davies TA; Ednie LM; Hoellman DM; Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1894-9. PubMed ID: 10858350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin).
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 1998 Apr; 42(4):945-6. PubMed ID: 9559816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of the ketolide ABT-773.
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2922-4. PubMed ID: 11557491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.
    Montanari MP; Mingoia M; Giovanetti E; Varaldo PE
    J Clin Microbiol; 2001 Apr; 39(4):1311-5. PubMed ID: 11283047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of a novel ketolide ABT-773 against invasive strains of Streptococcus pneumoniae.
    Weiss K; de Azavedo J; Restieri C; Quach C; Laverdiere M; Rubin E; Gourdeau M; Low DE
    J Antimicrob Chemother; 2001 Sep; 48(3):407-9. PubMed ID: 11533007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
    Bejuk D
    Acta Med Croatica; 2004; 58(4):301-6. PubMed ID: 15700686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents.
    Ednie LM; Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 May; 41(5):1033-6. PubMed ID: 9145864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents.
    Pankuch GA; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Mar; 42(3):624-30. PubMed ID: 9517943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children.
    Johnson CN; Benjamin WH; Gray BM; Crain MC; Edwards KM; Waites KB
    Int J Antimicrob Agents; 2001 Dec; 18(6):531-5. PubMed ID: 11738340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Streptococcus pneumoniae strains resistance to macrolide, lincosamide, streptogramin, oxazolidinone and ketolide].
    Sener B; Köseoğlu O; Fişenk I; Hasçelik G; Günalp A
    Mikrobiyol Bul; 2002 Apr; 36(2):125-31. PubMed ID: 12652863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of the ketolide telithromycin (HMR-3647) against erythromycin-susceptible and -resistant pneumococci isolated in the UK.
    Johnson AP; Henwood CJ; Tysall L; Warner M
    Int J Antimicrob Agents; 2001 Jul; 18(1):73-6. PubMed ID: 11463530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The phenotype and genotype patterns of erythromycin-resistant Streptococcus pneumoniae].
    Zhao TM; Liu YN
    Zhonghua Nei Ke Za Zhi; 2004 May; 43(5):329-32. PubMed ID: 15182500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of selection for mutants with reduced susceptibility to ABT-773, erythromycin and rifampicin in respiratory tract pathogens.
    Nilius AM; Hensey-Rudloff DM; Reimann MA; Flamm RK
    J Antimicrob Chemother; 2002 May; 49(5):831-6. PubMed ID: 12003979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the novel ketolide ABT-773: transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae.
    Capobianco JO; Cao Z; Shortridge VD; Ma Z; Flamm RK; Zhong P
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1562-7. PubMed ID: 10817709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.
    Giovanetti E; Montanari MP; Marchetti F; Varaldo PE
    J Antimicrob Chemother; 2000 Dec; 46(6):905-8. PubMed ID: 11102408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model.
    Kim MK; Zhou W; Tessier PR; Xuan D; Ye M; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3185-92. PubMed ID: 12234843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro bactericidal activities of ABT-773 against ermB strains of Streptococcus pneumoniae.
    Neuhauser MM; Prause JL; Danziger LH; Pendland SL
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1132-4. PubMed ID: 12604554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.